Sign In
Buy APYX
$4.10
-0.0200 (-0.485%)
At Close: Jul 31, 2026
Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors
07:01am, Thursday, 09'th Nov 2023
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvi
Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook
07:00am, Thursday, 09'th Nov 2023
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvi
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November
07:30am, Tuesday, 07'th Nov 2023
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvi
Are Medical Stocks Lagging Apyx Medical (APYX) This Year?
11:23am, Thursday, 26'th Oct 2023
Here is how Apyx Medical (APYX) and CymaBay Therapeutics Inc. (CBAY) have performed compared to their sector so far this year.
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023
07:30am, Monday, 02'nd Oct 2023
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx® Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renu
Apyx Medical Corporation (APYX) Q2 2023 Earnings Call Transcript
12:09pm, Saturday, 12'th Aug 2023
Apyx Medical Corporation (NASDAQ:APYX ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Charles Goodwin - President & CEO Tara Semb - CFO Conference Call Participants M
Apyx Medical (APYX) Reports Q2 Loss, Misses Revenue Estimates
07:01pm, Thursday, 10'th Aug 2023
Apyx Medical (APYX) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.16 per share a year ago.
Is Apyx Medical (APYX) Stock Outpacing Its Medical Peers This Year?
11:25am, Tuesday, 16'th May 2023
Here is how Apyx Medical (APYX) and Haemonetics (HAE) have performed compared to their sector so far this year.
Apyx Medical Corporation (APYX) Q1 2023 Earnings Call Transcript
10:21am, Thursday, 11'th May 2023
Apyx Medical Corporation (NASDAQ:APYX ) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Participants Charlie Goodwin - President & CEO Tara Semb - CFO Conference Call Participants Mat
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 16, 2023
07:30am, Thursday, 16'th Feb 2023
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvi
Archon Capital Ups Stake in Apyx Medical (APYX) After Q3 Results
04:22am, Wednesday, 23'rd Nov 2022
Fintel reports that Archon Capital Management LLC has filed a 13G/A form with the SEC disclosing ownership of 3,452,030 shares of Apyx Medical Corp (APYX).
Apyx Medical Corporation (APYX) Q3 2022 Earnings Call Transcript
11:28pm, Sunday, 13'th Nov 2022
Apyx Medical Corporation (NASDAQ:APYX ) Q3 2022 Earnings Conference Call November 10, 2022 8:00 AM ET Company Participants Charles Goodwin - President and Chief Executive Officer Tara Semb - Chief Fin
Apyx Medical (APYX) Reports Q3 Loss, Misses Revenue Estimates
09:47am, Thursday, 10'th Nov 2022
Apyx (APYX) delivered earnings and revenue surprises of -41.67% and 24.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Apyx Medical Corporation (APYX) CEO Charles Goodwin on Q2 2022 Results - Earnings Call Transcript
11:29am, Sunday, 14'th Aug 2022
Apyx Medical Corporation (NASDAQ:APYX ) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Charles Goodwin – President and Chief Executive Officer Tara Semb – Chief F
Apyx Medical's Renuvion Scores FDA Approval To Eliminate Sagging Neck
10:43am, Monday, 18'th Jul 2022
The FDA has granted 510(k) clearance for Apyx Medical Corporation's (NASDAQ: APYX) Renuvion for subcutaneous dermatological and aesthetic procedures to improve the appearance of lax skin in the ne
